Attitude and medical insurance coverage for off-label use in various countries
10.3760/cma.j.cn111325-20201120-02124
- VernacularTitle:国外对超说明书用药的态度和医保覆盖情况及其启示
- Author:
Rongji LIU
1
;
Ziran NIU
;
Wei ZUO
;
Yang HU
;
Bo ZHANG
Author Information
1. 中国医学科学院北京协和医院药剂科，北京 100730
- Keywords:
Off-label use;
Regulations and policy;
Reimbursement;
Supervision;
Patient rights
- From:
Chinese Journal of Hospital Administration
2021;37(10):838-842
- CountryChina
- Language:Chinese
-
Abstract:
Off-label drug use is a global problem in clinical practice. The management status, attitude and medical insurance coverage of off-label drug use are different in various countries. By analyzing the management and reimbursement policy of off-label drug use in other countries, the authors suggested that China should speed up the institutional arrangements of off-label drug use and establish relevant management systems, and strengthen the supervision of off-label drug use, so as to guarantee the rights of patients to the best treatment.
